| FDA backs Merck cholesterol drug to lower heart problems in kidney disease ... - Washington Post |
|
|
Washington Post However results varied depending on whether patients were receiving dialysis, standard treatment for patients with late-stage kidney disease who can no longer remove waste from their blood. Patients on dialysis only saw a six percent drop in heart |